ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Spectrum Pharmaceuticals, Inc
Assistance Publique - Hôpitaux de Paris
Novartis
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Arab American University (Palestine)
Incyte Corporation
First Affiliated Hospital of Ningbo University
Gruppo Italiano Malattie EMatologiche dell'Adulto
BPGbio
Gruppo Italiano Malattie EMatologiche dell'Adulto
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
Shanghai Simnova Biotechnology Co.,Ltd.
Myeloid Therapeutics
University College, London
AbbVie
Massachusetts General Hospital
Medical College of Wisconsin
M.D. Anderson Cancer Center
Chinese PLA General Hospital
AbbVie
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Assistance Publique - Hôpitaux de Paris
Shandong Provincial Hospital
Hoffmann-La Roche
Peking University
University of Guadalajara
Asan Medical Center
Hoffmann-La Roche
St. Jude Children's Research Hospital
Vanderbilt University Medical Center
National Cancer Center, Korea
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
Hoffmann-La Roche
AIDS Malignancy Consortium
Hoffmann-La Roche
Aalborg University Hospital
Burnasyan Federal Medical Biophysical Center
Yale University
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Children's Oncology Group
St. Jude Children's Research Hospital
National Cancer Institute (NCI)